Target intelligence / Profile preview

L-carnitine CoA-transferase (CaiB)

Target
CaiB
Molecular classification
Enzyme, CoA-transferase, Type-III CoA-transferase family
01

Overview

L-carnitine CoA-transferase is a bacterial enzyme, notably present in *Escherichia coli* and other gammaproteobacteria, that catalyzes the reversible transfer of a CoA group from gamma-butyrobetainyl-CoA or crotonobetainyl-CoA to L-carnitine, resulting in the formation of L-carnitinyl-CoA and gamma-butyrobetaine[2][4][5][7][8][9]. This enzyme (also called CaiB) is encoded by the cai operon, and is important in microbial carnitine and fatty acid metabolism. The enzyme belongs to the family III CoA-transferases and plays a central role in utilizing L-carnitine by enabling bacteria to produce energy from carnitine substrates under certain conditions[5][8]. The CaiB enzyme has been structurally characterized (dimer of subunits, with a Rossmann fold domain)[7]; its catalytic mechanism involves a covalent intermediate with an aspartate residue, allowing transfer of the CoA group between substrates[5][7]. Important note: L-carnitine CoA-transferase (CaiB) should not be confused with carnitine acetyltransferase (CRAT) or mitochondrial carnitine palmitoyltransferase enzymes, which are important in human fatty acid metabolism and disease. L-carnitine CoA-transferase is primarily characterized in bacteria and does not have a direct therapeutic or disease role in humans[2][4][5][7][8].

Other names
CaiBcrotonobetainyl/gamma-butyrobetainyl-CoA:carnitine CoA-transferasecrotonobetainyl-CoA:L-carnitine CoA-transferasegamma-butyrobetainyl-CoA:L-carnitine CoA-transferase
02

Mechanism of action

Catalyzes reversible transfer of CoA from gamma-butyrobetainyl-CoA (or crotonobetainyl-CoA) to L-carnitine, generating L-carnitinyl-CoA and gamma-butyrobetaine

03

Biological functions

Carnitine metabolismFatty acid metabolism (in bacteria)Energy metabolism
04

Disease associations

Not directly associated with major human diseasesRole primarily in bacteriaNo clear human disease association as with related eukaryotic carnitine acyltransferases

Beyond the preview

Go deeper on L-carnitine CoA-transferase (CaiB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on L-carnitine CoA-transferase (CaiB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call